Company Overview

Name of Company

3-D Matrix, Ltd.

Date of
Establishment

May 19, 2004

Capital

8,053,861,000 JPY (as of the end of Oct. 2019)

Management
Team

Chairman and Executive Director	Keiji Nagano
President and Representative Director	Jun Okada
Director	Tomoyuki Arai
Outside Director	Kazuya Shimamura	Attorney-at-law/certified public accountant
Director	Satoru Kobayashi
Director	Takao Miki
Director	Toshi Amanuma
Director	Ryuhei Mogi
Executive Officer	Andy Kim
Executive Officer	Marie Buffier
Standing Statutory Auditor	Tsutomu Kawabe	Labor and social security attorney
Outside Auditor	Toshihiro Hanyu	Certified public accountant
Outside Auditor	Noriyuki Okawara	Attorney-at-law
Medical, Science and Technology Adviser	Robert S. Langer	Professor of the Department of Chemical Engineering at the Massachusetts Institute of Technology
	Bengt Norden	Professor at the Chalmers University of Technology

	Tatsutoshi Nakahata	Professor of the Center for iPS Cell Research and Application, Kyoto University
	Yoshikaki Hirano	Professor of the Department of Chemistry and Materials Engineering at Kansai University
	Takashi Noguchi	Director of the RICOGs
	Mamoru Nomura	The Japanese Society of Toxicology Diplomate of the Japanese Society of Toxicology (DJSOT)/ Emeritus Diplomate of the Japanese Society of Toxicology (Emeritus DJSOT)
	Ikkei Matsuda	Representative executive officer of SARR, LLC Affiliate professor of the Chuo Graduate School of Strategic Management
Founder	Shuguang Zhang	Head, Laboratory of Molecular Architecture, The Media Lab, at the Massachusetts Institute of Technology

Financing Banks

Sumitomo Mitsui Banking Corporation (Koishikawa branch)
Mizuho Bank, Ltd. (Kanda branch)
Resona Bank, Ltd. (Shintoshin Banking Department)

Obtained License

First-Class Medical Devices Marketing License

Obtained Certification

ISO 13485 (international standard for quality management system of medical devices)

Activities

A self-assembled peptide was discovered in 1992 by Dr. Shuguang Zhang of MIT. Our company is globally developing businesses based on various rights associated with self-assembling peptide technology licensed from MIT.

Learn More